Metformin promotes apoptosis in colorectal cancer through the miR-211-5p/MMP9 pathway
Advances in Cancer Biology - Metastasis · 2026-12 · 18 · 100202
DOI: 10.1016/j.adcanc.2026.100202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Cancer Biology - Metastasis, 2026-12. Verfasst von Ensiyeh Bahadoran und 4 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qazvin University of Medical Sciences.
Abstract (Originalsprache)
Background and Aims Recent studies have shown that metformin can positively affect colorectal cancer (CRC) prevention and treatment. This study investigated whether metformin exerts its antitumor effects by modulating the miR-211-5p/MMP9 axis in CRC cells.
Methods
SW480 and SW620 CRC lines were treated with 5 mM metformin for 48 h, and the experimental groups consisted of metformin-treated and untreated control cells. Cell viability, apoptosis, migration, and protein expression were evaluated using Cell Counting Kit-8 (CCK-8), flow cytometry, wound healing assay, and western blot analysis, respectively. The expression levels of miR-211-5p and MMP9 were determined by quantitative real-time PCR (qRT-PCR). Gain- and loss-of-function experiments were performed using miR-211-5p mimic and inhibitor, and a dual-luciferase reporter assay was conducted to validate MMP9 as a direct target of miR-211-5p . Differences between the two groups were analyzed using Student’s t-test, while comparisons among multiple groups were conducted using one-way analysis of variance (ANOVA).
Results
Metformin significantly reduced cell viability and induced apoptosis in both SW480 and SW620 cells. It upregulated the expression of miR-211-5p while suppressing MMP9 at both the mRNA and protein levels. Luciferase reporter assay confirmed that MMP9 is a direct target of miR-211-5p . Overexpression of miR-211-5p further enhanced the antiproliferative and pro-apoptotic effects of metformin. Moreover, the combined treatment with metformin and miR-211-5p mimic markedly inhibited CRC cell migration compared with either treatment alone.
Conclusion
Metformin suppresses colorectal cancer progression by modulating the miR-211-5p/MMP9 axis, resulting in reduced cell viability, enhanced apoptosis, and impaired cell migration. These findings suggest that the miR-211-5p/MMP9 axis may contribute to the anticancer effects of metformin.
Förderung
- Qazvin University of Medical Sciences
Zitieren
APA
Bahadoran, E., Zafari, Y., Mohammadi, D., Neshat, S., & Moghbelinejad, S. (2026). Metformin promotes apoptosis in colorectal cancer through the miR-211-5p/MMP9 pathway. Advances in Cancer Biology - Metastasis, 18, 100202. https://doi.org/10.1016/j.adcanc.2026.100202
Vancouver
Bahadoran E, Zafari Y, Mohammadi D, Neshat S, Moghbelinejad S. Metformin promotes apoptosis in colorectal cancer through the miR-211-5p/MMP9 pathway. Advances in Cancer Biology - Metastasis. 2026;18:100202. doi:10.1016/j.adcanc.2026.100202
BibTeX
@article{Bahadoran2026,
author = {Bahadoran, Ensiyeh and Zafari, Yazdan and Mohammadi, Davood and Neshat, Sina and Moghbelinejad, Sahar},
title = {Metformin promotes apoptosis in colorectal cancer through the miR-211-5p/MMP9 pathway},
journal = {Advances in Cancer Biology - Metastasis},
year = {2026},
volume = {18},
pages = {100202},
doi = {10.1016/j.adcanc.2026.100202}
}
EUVIMED